Skip to main content
. 2016 Oct 14;12(6):4838–4844. doi: 10.3892/ol.2016.5265

Figure 4.

Figure 4.

Survival analysis of patients with CRC with high or low miR-23b expression in the plasma. (A) CRC patients with a high miR-23b level had an improved overall survival rate (P=0.005). (B) CRC patients with high miR-23b expression showed a longer recurrence-free survival time (P=0.02). miR-23b, microRNA-23b; CRC, colorectal cancer.